Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2009
08/11/2009US7572576 Analyzing two or more polymorphisms selected from among 4 gene polymorphisms having been revealed as relating to hypertension determining the genotype of a nucleic acid sample based on the polymorphism data obtained in first step, predicting the genetic risk ; high accuracy
08/11/2009US7572575 Identifying modulator of transcriptional activity of silent information regulator (SIR) for treat cell proliferative diseases; antitumor agents
08/11/2009US7572574 Method of measuring neprilysin activity
08/11/2009US7572455 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition
08/11/2009US7572434 In drosophila, aplysia, and rodents; one isoform (dcreb2-a) encodes a cyclic 3',5'-adenosine monophosphate (camp)-responsive transcriptional activator, another isoform (dcreb2-b) codes for an antagonist which blocks the activator
08/11/2009US7572409 Ionic liquid apparatus and method for biological samples
08/11/2009CA2546660C Selective inhibitors of viral or bacterial neuraminidase
08/11/2009CA2438574C Method of detecting nucleotide polymorphism
08/11/2009CA2398523C Reducing e. coli content of beef
08/11/2009CA2342300C Mutant luciferase having increased thermostability
08/11/2009CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity
08/11/2009CA2327254C Chemically modified mutant enzymes and methods for producing them and screening them
08/11/2009CA2289283C Metastasis models using green fluorescent protein (gfp) as a marker
08/11/2009CA2271248C Use of a notch ligand in immunotherapy
08/11/2009CA2255113C Conductive metal-containing nucleic acids
08/11/2009CA2224404C Cell volume-regulated human kinase h-sgk
08/11/2009CA2192940C Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
08/11/2009CA2178048C Dry analytical element for acetaminophen assay
08/07/2009CA2618163A1 Head and neck cancer biomarkers
08/06/2009WO2009097626A2 Paired-end reads in sequencing by synthesis
08/06/2009WO2009097593A1 Single nucleotide polymorphisms associated with renal disease
08/06/2009WO2009097466A1 Method for automatically and rapidly distinguishing between control and sample solutions in a biosensor strip
08/06/2009WO2009097429A1 A fast acting primary hemostatic agent
08/06/2009WO2009097418A2 Sr-bi as a predictor of elevated high density lipoprotein and cardiovascular disease
08/06/2009WO2009097368A2 Methods and compositions for efficient base calling in sequencing reactions
08/06/2009WO2009097357A1 Analyte sensors having nanostructured electrodes and methods for making and using them
08/06/2009WO2009097339A1 Methods of monitoring metabolic pathways
08/06/2009WO2009097318A1 A fluorescence polarization binding assay for characterizing glucokinase ligands
08/06/2009WO2009097270A2 Method of determining breast cancer risk
08/06/2009WO2009097262A2 Chitotriosidase and methods of use thereof
08/06/2009WO2009097136A1 Methods and compositions relating to carcinoma stem cells
08/06/2009WO2009097014A2 Therapeutic kinase modulators
08/06/2009WO2009096429A1 Method for extraction of nucleotide
08/06/2009WO2009096102A1 Method for measuring yeast aggregation activity of malt using crystal oscillator
08/06/2009WO2009095897A1 Biomarkers for hypoxic situations and uses
08/06/2009WO2009095840A1 Method for simultaneous detection of pathogens and genetic profiling of the host using a single array
08/06/2009WO2009095826A2 Optical indicator for detecting bacterial pathogens
08/06/2009WO2009095786A2 Methods and kits for the rapid determination of patients at high risk of death during septic shock
08/06/2009WO2009095729A1 Methods for the detection and quantification of nematode parasites in fish and fish products
08/06/2009WO2009095641A2 Enhanced plant growth
08/06/2009WO2009095596A2 Method, process, and kit for diagnosis or prognosis of colorectal cancer
08/06/2009WO2009095567A2 Method for studying v(d)j combinatory diversity
08/06/2009WO2009095520A1 Method for defining and producing reactive chemical nanomemtric surface patterns by means of gaseous-phase soft lithography, resulting patterns and devices and uses thereof
08/06/2009WO2009095319A1 Cancer prognosis by majority voting
08/06/2009WO2009095258A1 Identification of antibiotic resistance using labelled antibiotics
08/06/2009WO2009094713A1 Diagnosis and treatment of sensory defect
08/06/2009WO2009074892A3 Fiber optic based detection of autofluorescent bacterial pathogens
08/06/2009WO2009068591A3 Biomarkers for the onset of neurodegenerative diseases
08/06/2009WO2009059021A3 Hcv genotyping and phenotyping
08/06/2009WO2009054996A9 Systems and methods for viral therapy
08/06/2009WO2009047002A3 Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies
08/06/2009WO2009045403A3 MENIN REGULATION OF β-ISLET CELL PROLIFERATION
08/06/2009WO2009019657A3 Means for diagnosis and treatment of rheumatoid arthritis
08/06/2009WO2008157640A3 Microfabrication methods for the optimal patterning of substrates
08/06/2009WO2008121727A8 Identification of the causative mutation for hereditary equine regional dermal asthenia and a method for testing same
08/06/2009WO2008049022A8 Methods for detection of cancer
08/06/2009WO2008047234A8 A molecule for providing a standard for the quantitative analysis of the methylation status of a nucleic acid
08/06/2009WO2007149981A8 Methods of gene expression analysis
08/06/2009WO2007131071A8 Mig-7 as a specific anticancer target
08/06/2009WO2004063856A3 Identifying items with nucleic acid taggants
08/06/2009WO2002074782A3 Isolation and purification procedure of vasopeptidase peptide inhibitors
08/06/2009WO2002004470A3 Haplotypes of the gcnt1 gene
08/06/2009WO2000015839A9 Method for determining susceptibility to bone damage by screening polymorphisms in the vitamin d receptor gene
08/06/2009US20090199313 Non-mevalonate isoprenoid pathway
08/06/2009US20090199306 Fucosyl transferase gene
08/06/2009US20090198451 Integrated Biosensor and Simulation System for Diagnosis and Therapy
08/06/2009US20090198450 Integrated Biosensor and Simulation System for Diagnosis and Therapy
08/06/2009US20090198336 Cell co-culture for hair follicle production
08/06/2009US20090198117 Analyte sensors having nanostructured electrodes and methods for making and using them
08/06/2009US20090198047 2'-Modified Oligonucleotides
08/06/2009US20090197953 Pharmaceutical composition for the specific treatment of acute myeloid leukemia
08/06/2009US20090197947 Medicaments and methods for lowering plasma lipid levels and screening drugs
08/06/2009US20090197945 Method for Generating Reference Controls for Pharmacogenomic Testing
08/06/2009US20090197937 Marine actinomycete taxon for drug and fermentation product discovery
08/06/2009US20090197893 Methods of Identifying and Treating Individuals Exhibiting Complex Karyotypes
08/06/2009US20090197858 Hypercholestrolemia and tendinous injuries
08/06/2009US20090197854 Use of picoplatin to treat colorectal cancer
08/06/2009US20090197853 Methods and compositions of treating cancer
08/06/2009US20090197817 Tetrahdrofuro[3,2-B] pyrrol-3- one as cathepsin k inhibitors
08/06/2009US20090197809 Antifungal methods
08/06/2009US20090197808 decreasing white blood cell proliferation; by use of recombinant human CC10 (rhCC10), also known as recombinant human uteroglobin
08/06/2009US20090197794 Methods of Diagnosing and Treating an Inflammatory Response
08/06/2009US20090197776 Liquid Tissue Preparation From Histopathologically Processed Biological Samples, Tissues and Cells
08/06/2009US20090197775 Nuclease on chip
08/06/2009US20090197774 Method for diagnosing thromboembolic disorders and coronary heart disease
08/06/2009US20090197346 Compositions and methods for preserving rna in biological samples
08/06/2009US20090197342 measuring the level of pregnancy-associated plasma protein-A (PAPP-A) in a biological sample from a non-pregnant patient and comparing the level with that of control subjects
08/06/2009US20090197306 Thermal cycling device
08/06/2009US20090197299 Method for Assessing Airborn Microorganisms
08/06/2009US20090197298 Method for detecting microorganisms in a biological sample
08/06/2009US20090197297 Molecularly Imprinted Polymer Sensor Device
08/06/2009US20090197296 Optical Indicator for Detecting Bacterial Pathogens
08/06/2009US20090197295 Masks useful for maldi imaging of tissue sections, processes of manufacture and uses thereof
08/06/2009US20090197294 Mrd-based reactors
08/06/2009US20090197293 Novel use of an indicator cell line for bioassay
08/06/2009US20090197292 Systems and methods for ex vivo lung care
08/06/2009US20090197291 Assays Using Nanoparticles
08/06/2009US20090197290 Methods and Kits for Diagnosis of Non-Septic Shock
08/06/2009US20090197289 Method for confirming a diagnosis of autism
08/06/2009US20090197288 Multiple quantification of cholesterol in low density lipoprotein
1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 3003